New obesity pill shows promise in major trial
NCT ID NCT06841445
First seen Apr 14, 2026 · Last updated May 22, 2026 · Updated 8 times
Summary
This study tested a new tablet called HRS9531 to help people with obesity lose weight. 166 adults with a BMI between 28 and 40 took either the drug or a placebo for 26 weeks. The main goal was to see how much weight they lost compared to those on placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MANAGEMENT OF BODY WEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Drum Tower hospital
Nanjing, Jiangsu, 210008, China
Conditions
Explore the condition pages connected to this study.